Cortenema Interactions
There are 642 drugs known to interact with Cortenema (hydrocortisone), along with 23 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 88 are major, 517 are moderate, and 37 are minor.
- View all 642 medications that may interact with Cortenema
- View Cortenema alcohol/food interactions (2)
- View Cortenema disease interactions (23)
Most frequently checked interactions
View interaction reports for Cortenema (hydrocortisone) and the medicines listed below.
- albuterol
- Asacol (mesalamine)
- balsalazide
- Benadryl (diphenhydramine)
- budesonide
- Canasa (mesalamine)
- cephalexin
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- Flagyl (metronidazole)
- Flexeril (cyclobenzaprine)
- fluconazole
- Fluzone High-Dose (influenza virus vaccine, inactivated)
- Humira (adalimumab)
- hydrochlorothiazide
- levalbuterol
- Lexapro (escitalopram)
- Lialda (mesalamine)
- magnesium glycinate
- mercaptopurine
- mesalamine
- metformin
- multivitamin
- omeprazole
- pantoprazole
- prednisone
- Uceris (budesonide)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Cortenema alcohol/food interactions
There are 2 alcohol/food interactions with Cortenema (hydrocortisone).
Cortenema disease interactions
There are 23 disease interactions with Cortenema (hydrocortisone) which include:
- infections
- prematurity
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Cortenema (hydrocortisone)
- Cortenema consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.